Ineffective medicines to be removed from Uzbekistan's clinical treatment protocols

Each year, Uzbekistan spends between $600 million and $700 million on drugs whose effectiveness has not been proven or sufficiently studied. These drugs account for 42% of the country’s pharmaceutical imports.

In contrast, developed countries rely on evidence-based medicine and use drugs whose efficacy and safety have been proven through large-scale clinical trials.

The Ministry of Health has been instructed to begin removing from clinical protocols all medications identified by internationally recognized sources as "ineffective or insufficiently studied."

A comprehensive review will be carried out across all medical institutions — especially pediatric hospitals — to verify the justified use of antibiotics. Disciplinary measures will be taken against medical staff who do not follow established protocols.

The Prosecutor General’s Office has been tasked with ensuring accountability for the illegal sale of prescription drugs.

Additionally, the "E-prescription" system is to be fully implemented in the Yunusabad district of Tashkent and will serve as a model for expansion nationwide.